In a recent study, Keklikoglou et al. showed that cytotoxic chemotherapy could elicit the release of pro-metastatic EVs enriched with pro-metastatic molecules ANXA6 and Ly6C+CCR2+ in mouse BC models. Here, ANXA6 is linked to breast cancer.